MAIN INDICATIONS
MD-LUMBAR is a medical device designed to improve joint movement of the lumbosacral spine area and to reduce associated pain, counteracting physiological or pathological deterioration of the joints and tissues involved.
Clinical evidence shows the effectiveness and safety of MD-LUMBAR at improving movement and reducing lower back pain due to various causes and origins, such as:
• Lumbar instability due to degenerative spondylolisthesis, lumbar spondylosis, herniated discs in the lumbar vertebrae and non-specific low back pain, such as in the case of prolonged bed rest or poor ambulation.
• Chronic lumbosciatica:
− due to aging
− due to bad posture
− due to concomitant chronic diseases
− due to traumas and injuries.
• Facet joint syndrome.
Treatment can be combined with other therapies.
THERAPEUTIC PROTOCOL:
Periarticular administration: 1 treatment per week: subcutaneous injection in the trigger points and/or in the periarticular area of one (2 ml) or two vials (4 ml) per treatment. Results are evident from the third week but, depending on the patient’s clinical situation, it is possible to continue treatment up to the tenth week without risk.
COMPOSITION
Collagen of porcine origin, Hamamelis, NaCl, Water for injection.
PACKAGE
Box of 10 vials (single vial 2 ml – extraction volume).
INJECTION ROUTES OF ADMINISTRATION
Periarticular and intramuscular (trigger points).
SUGGESTED NEEDLE
Periarticular: 26G x 16 mm needle.
Note: Disinfect the skin thoroughly with iodopovidone or chlorhexidine.
INJECTION TECHNIQUES OF ADMINISTRATION
• Periarticular administration: insert the needle near to the lumbar, lumbo-sacral, and sacroiliac joints to a depth of 10-12 mm.
• Intramuscular administration: insert the needle into the trigger points at a depth of 10-12 mm.